Does the Timing of Immunotherapy Administration Affect Outcomes in Advanced Cancers? - Takeaways - MDSpire
From the Journals

Does the Timing of Immunotherapy Administration Affect Outcomes in Advanced Cancers?

A systematic review and meta-analysis found that early time-of-day immunotherapy was associated with improved survival outcomes in patients with advanced cancers, with the association appearing to be ...

  • By

  • The ASCO Post Staff

  • May 14, 2026

  • 3 min

Share

  • 1

    Early time-of-day immunotherapy improves survival in advanced cancers.

  • 2

    Significant findings in non-small cell lung cancer and other malignancies.

  • 3

    Study includes 29 randomized and cohort studies.

  • 4

    Circadian rhythms may affect immunotherapy efficacy.

  • 5

    Current evidence requires further prospective studies.

  • 6

    Overall survival hazard ratio found to be 0.

  • 7

    Further research needed for standardized timing strategies.

Original Source(s)

Does the Timing of Immunotherapy Administration Affect Outcomes in Advanced Cancers?

  • by The ASCO Post Staff

  • May 14, 2026

Related Content

Combination Enzalutamide and Radium-223 Extends Overall Survival in Bone-Dominant mCRPC

In the final analysis of the phase III EORTC 1333/PEACE-3 trial, with a median follow-up of 58 months, the addition of radium-223 to the androgen receptor inhibitor enzalutamide significantly prolonge...

Lack of Research in Understanding the Global Population of Childhood Cancer Survivors Leads to Gaps in Care and Cures

Each year, globally, about 400,000 children and adolescents aged between 0 and 19 years are diagnosed with cancer; over 100,000 die from the disease, with most of those cases, over 80%, and deaths occ...

New Clues in Hodgkin Lymphoma Biology

Transcriptome analysis highlights diagnostic targets and immune evasion pathways

  • May 14, 2026

  • 2 min